PT2197456E - Composi??es oft?lmicas baseadas em polissac?rido de semente de tamarindo e ?cido hialur?nico - Google Patents

Composi??es oft?lmicas baseadas em polissac?rido de semente de tamarindo e ?cido hialur?nico Download PDF

Info

Publication number: PT2197456E
Authority: PT; Portugal
Prior art keywords: hyaluronic acid; combination; tamarind seed; compositions based; seed polysaccharide
Prior art date: 2007-10-02

Application number

PT08835989T

Other languages

English (en)

Inventor

Antonio Del Prete

Marco Sanso

Original Assignee

Hmfra Hungary Korl Tolt Felel Ss G T Rsas G

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-10-02

Filing date

2008-10-02

Publication date

2011-05-18

2008-10-02 Application filed by Hmfra Hungary Korl Tolt Felel Ss G T Rsas G filed Critical Hmfra Hungary Korl Tolt Felel Ss G T Rsas G

2011-05-18 Publication of PT2197456E publication Critical patent/PT2197456E/pt

Links

KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title abstract 3
235000004298 Tamarindus indica Nutrition 0.000 title abstract 3
150000004676 glycans Chemical class 0.000 title abstract 3
229920002674 hyaluronan Polymers 0.000 title abstract 3
229960003160 hyaluronic acid Drugs 0.000 title abstract 3
229920001282 polysaccharide Polymers 0.000 title abstract 3
239000005017 polysaccharide Substances 0.000 title abstract 3
240000004584 Tamarindus indica Species 0.000 title abstract 2
239000000203 mixture Substances 0.000 title 1
208000003556 Dry Eye Syndromes Diseases 0.000 abstract 2
206010013774 Dry eye Diseases 0.000 abstract 2
241000596504 Tamarindus Species 0.000 abstract 1
239000007864 aqueous solution Substances 0.000 abstract 1
230000001939 inductive effect Effects 0.000 abstract 1
210000000110 microvilli Anatomy 0.000 abstract 1
210000004877 mucosa Anatomy 0.000 abstract 1
239000002997 ophthalmic solution Substances 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1
230000004936 stimulating effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Natural Medicines & Medicinal Plants (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Ophthalmology & Optometry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Botany (AREA)
Dermatology (AREA)
Alternative & Traditional Medicine (AREA)
Biotechnology (AREA)
Inorganic Chemistry (AREA)
Medical Informatics (AREA)
Microbiology (AREA)
Mycology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines Containing Plant Substances (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PT08835989T 2007-10-02 2008-10-02 Composi??es oft?lmicas baseadas em polissac?rido de semente de tamarindo e ?cido hialur?nico PT2197456E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT000510A ITRM20070510A1 (it)	2007-10-02	2007-10-02	Composizioni oftalmiche a base di polisaccaride del seme di tamarindo e acido ialuronico.

Publications (1)

Publication Number	Publication Date
PT2197456E true PT2197456E (pt)	2011-05-18

Family

ID=40314052

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT08835989T PT2197456E (pt)	2007-10-02	2008-10-02	Composi??es oft?lmicas baseadas em polissac?rido de semente de tamarindo e ?cido hialur?nico

Country Status (14)

Country	Link
US (1)	US8455462B2 (pt)
EP (1)	EP2197456B1 (pt)
JP (1)	JP5542674B2 (pt)
KR (1)	KR101570966B1 (pt)
AT (1)	ATE499106T1 (pt)
CA (1)	CA2701721C (pt)
DE (1)	DE602008005173D1 (pt)
ES (1)	ES2361529T3 (pt)
IT (1)	ITRM20070510A1 (pt)
MX (1)	MX2010003488A (pt)
PL (1)	PL2197456T3 (pt)
PT (1)	PT2197456E (pt)
RU (1)	RU2493855C2 (pt)
WO (1)	WO2009044423A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE429209T1 (de) *	2005-02-09	2009-05-15	Safilens S R L	Kontaktlinse, verfahren zu ihrer herstellung und packung zur aufbewahrung und pflege einer kontaktlinse
IT1396607B1 (it) *	2009-11-16	2012-12-14	Hmfra Hungary Ltd Liability Company	Preparazioni oftalmiche a base di bdnf (brain-derived neurotrophic factor) e loro uso.
EP2575971B1 (en) *	2010-05-24	2015-12-16	Indena S.p.A.	Combined plant extracts for use in the treatment of microbial infections
BR112012029697A2 (pt) *	2010-05-24	2016-08-02	Indena Spa	polissacarídeo da semente de tamarindo para uso no tratamento de doenças inflamatórias
FR2963240B1 (fr) *	2010-07-28	2013-03-15	Horus Pharma	Composition a usage topique sans conservateur comprenant de l'acide hyaluronique
IT1404145B1 (it) *	2010-12-27	2013-11-15	Altergon Sa	Composizioni di acido ialuronico stabilizzate verso l'azione di degradazione del calore o degli enzimi
EP2883931A1 (en) *	2013-12-12	2015-06-17	Omya International AG	Improved gel stability
CA2945631C (en)	2014-04-15	2023-04-11	Novintethical Pharma Sa	Compositions based on xyloglucan and proteins for the treatment of intestinal disorders
US11623008B2 (en) *	2014-08-20	2023-04-11	Professional Compounding Centers Of America	Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan
EP3103438B1 (en)	2015-06-11	2018-11-14	Novintethical Pharma SA	Topical nasal compositions containing xyloglucans for use as decongestans
SG10201913468YA (en) *	2015-07-13	2020-03-30	Tohoku Techno Arch Co Ltd	Composition for optic nerve protection
AR108280A1 (es) *	2016-05-05	2018-08-08	Acraf	Composición oftálmica que comprende una combinación sinérgica de glucógeno y ácido hialurónico o sal del mismo
IT201600108848A1 (it) *	2016-10-27	2018-04-27	Giuliani Spa	Composizioni dermatologiche
WO2019025986A1 (en) *	2017-08-02	2019-02-07	Shilpa Medicare Limited	OPHTHALMIC COMPOSITIONS OF CYCLOSPORINE
US11129862B2 (en) *	2017-08-30	2021-09-28	Johnson & Johnson Consumer Inc.	Ophthalmic compositions
MA53171A (fr) *	2018-07-18	2021-05-26	Atg 20 S R L	Composition comprenant de la glycyrrhizine et ses utilisations cosmétiques et pharmaceutiques

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL80298A (en) *	1986-10-14	1993-01-31	Res & Dev Co Ltd	Eye drops
IT1283911B1 (it) *	1996-02-05	1998-05-07	Farmigea Spa	Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
IL135258A0 (en) *	1997-09-26	2001-05-20	Noven Pharma	Bioadhesive compositions and methods for topical administration of active agents
JP2002533379A (ja) *	1998-12-23	2002-10-08	イデアアクチェンゲゼルシャフト	生体内における局所的に非侵襲性である用途のための改善された製剤
AU2004283091A1 (en) *	2003-10-03	2005-05-06	Allergan, Inc.	Compositions and methods comprising prostaglandin-related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia
ATE429209T1 (de)	2005-02-09	2009-05-15	Safilens S R L	Kontaktlinse, verfahren zu ihrer herstellung und packung zur aufbewahrung und pflege einer kontaktlinse
TWI393567B (zh) *	2005-03-31	2013-04-21	Bausch & Lomb	治療乾眼之組合物及相關之製造方法及使用方法

2007
- 2007-10-02 IT IT000510A patent/ITRM20070510A1/it unknown
2008
- 2008-10-02 EP EP08835989A patent/EP2197456B1/en active Active
- 2008-10-02 CA CA2701721A patent/CA2701721C/en active Active
- 2008-10-02 DE DE602008005173T patent/DE602008005173D1/de active Active
- 2008-10-02 AT AT08835989T patent/ATE499106T1/de active
- 2008-10-02 US US12/681,256 patent/US8455462B2/en not_active Expired - Fee Related
- 2008-10-02 PT PT08835989T patent/PT2197456E/pt unknown
- 2008-10-02 ES ES08835989T patent/ES2361529T3/es active Active
- 2008-10-02 KR KR1020107006416A patent/KR101570966B1/ko not_active Expired - Fee Related
- 2008-10-02 PL PL08835989T patent/PL2197456T3/pl unknown
- 2008-10-02 RU RU2010117173/15A patent/RU2493855C2/ru active
- 2008-10-02 JP JP2010527598A patent/JP5542674B2/ja active Active
- 2008-10-02 MX MX2010003488A patent/MX2010003488A/es active IP Right Grant
- 2008-10-02 WO PCT/IT2008/000626 patent/WO2009044423A1/en not_active Ceased

Also Published As

Publication number	Publication date
ES2361529T3 (es)	2011-06-17
JP5542674B2 (ja)	2014-07-09
ITRM20070510A1 (it)	2009-04-03
KR101570966B1 (ko)	2015-11-23
KR20100091151A (ko)	2010-08-18
DE602008005173D1 (de)	2011-04-07
EP2197456B1 (en)	2011-02-23
RU2493855C2 (ru)	2013-09-27
ATE499106T1 (de)	2011-03-15
WO2009044423A1 (en)	2009-04-09
PL2197456T3 (pl)	2012-07-31
RU2010117173A (ru)	2011-11-10
MX2010003488A (es)	2010-08-31
CA2701721A1 (en)	2009-04-09
JP2010540619A (ja)	2010-12-24
US20100279981A1 (en)	2010-11-04
CA2701721C (en)	2016-02-23
EP2197456A1 (en)	2010-06-23
US8455462B2 (en)	2013-06-04

Similar Documents

Publication	Publication Date	Title
PL2197456T3 (pl)	2012-07-31	Kompozycje oftalmiczne na bazie polisacharydu z nasion tamaryndowca i kwasu hialuronowego
MY159463A (en)	2017-01-13	Method and composition for treating ocular hypertension and glaucoma
MY210233A (en)	2025-09-04	Methods and compositions for topical delivery
IN2012DN03632A (pt)	2015-06-26
JP2010540619A5 (pt)	2011-11-17
MX2010003774A (es)	2010-04-27	Formulaciones oftalmicas acuosas.
MY191349A (en)	2022-06-17	New pharmaceutical compositions for the treatment of hyper-proliferative disorders
MX2010004834A (es)	2010-10-20	Composiciones de analogos de prostaglandina y metodos para tratar las condiciones relacionadas al epitelio.
BRPI0519508A2 (pt)	2009-03-17	análogos de aminopirazina para tratamento de glaucoma e outras doenças ou condições mediadas por rho cinase
NZ608202A (en)	2014-08-29	Agent for treatment of dry eye characterized by combining p2y2 receptor agonist and hyaluronic acid or salt thereof, method for treating dry eye, and use of the p2y2 receptor agonist and hyaluronic acid or salt thereof
TN2011000416A1 (en)	2013-03-27	Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient
MX2019000586A (es)	2021-06-15	Virus adenoasociados (aav) sflt-1 para usarse en el tratamiento de degeneración macular relacionada con la edad (amd).
MX2009004467A (es)	2009-07-27	Compuestos benzoilo amino heterociclilo como activadores de la glucoquinasa (glk).
UA95105C2 (ru)	2011-07-11	Применение производного лактамида для снижения токсичности в препарате, который может соприкасаться с кожей или глазами человека или животного, производные лактамида и способы их получения
TW200833341A (en)	2008-08-16	6-aminoimidazo[1,2-b]pyridazine analogs as rho kinase inhibitors for the treatment of rho kinase-mediated diseases and conditions
MY144992A (en)	2011-12-15	Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
WO2009024677A3 (fr)	2009-12-03	Utilisation d ' acide hyaluronique pour la preparation de compositions destinees a l' amelioration de la fonction de protection de la peau, de l' oeil et des muqueuses
MY179527A (en)	2020-11-10	Catecholamine derivatives useful for the treatment of parkinson's disease
MX2012003759A (es)	2012-07-23	Metodos y composiciones para tratamiento de fibrosis ocular.
MY149505A (en)	2013-09-13	Hyaluronic acid binary mixtures and therapeutic use thereof
NO20083905L (no)	2008-09-12	Nye pyron-indol derivater og fremgangsmate for deres fremstilling
TNSN08321A1 (en)	2009-12-29	Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof
WO2021074649A3 (en)	2021-07-22	Methods of promoting scfa production by gut microbiota
UA95224C2 (ru)	2011-07-25	Антацидная фармацевтическая композиция в порошковой форме, фармацевтическое средство, ее содержащее, и способ ее получения
SG179131A1 (en)	2012-04-27	Modified erythropoietin to which water-soluble long-chain molecule is added